Ultomiris (ravulizumab)
pCPA File Number:
22427
Negotiation Status:
Negotiations were not pursued
Indication(s):
Generalized Myasthenia Gravis, AChR antibody-positive
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0765-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: